2024
|
Invention
|
P2x4 receptor antagonist.
A diazepine derivative represented by formula (I), where R1 and R2 rep... |
|
Invention
|
Biochemical reaction substrate and analyzer.
Provided is a biochemical reaction substrate which ... |
|
Invention
|
Use of morphinan derivatives for treatment of opioid delta receptor agonist-related disease.
A m... |
|
Invention
|
Spirocyclic morphinan derivative. [Problem] To provide a spirocyclic morphinan derivative having ... |
|
Invention
|
Solid dispersion of compound having p2x4 receptor antagonism. The present invention provides a so... |
|
Invention
|
Pharmaceutical for treating or preventing chemotherapy-induced peripheral neuropathy. Provided is... |
|
Invention
|
Pharmaceutical for treating or preventing peripheral neuropathy. Provided is a pharmaceutical com... |
2023
|
Invention
|
Medicament for treating cough.
The present invention pertains to a medicament for preventing or ... |
|
Invention
|
Pharmaceutical composition for preventing or suppressing or treating symptoms accompanying pseudo... |
|
Invention
|
Prophylactic agent or therapeutic agent for endometriosis or adenomyosis. The present invention p... |
|
G/S
|
Diagnostic reagents for medical research; Diagnostic reagent kits consisting of chemical reagents... |
|
Invention
|
Morphinan derivative.
A morphinan derivative represented by the following general formula (I):
... |
2022
|
Invention
|
Use of morphinan derivatives for treatment of opioid delta receptor agonist-related disease. A me... |
|
Invention
|
Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome.
... |
|
Invention
|
Agent for preventing or treating respiratory disease. The present invention relates to a pharmace... |
|
Invention
|
Medicament comprising a p2x4 receptor antagonist for preventing or treating nociceptive pain and/... |
|
Invention
|
Prophylactic or therapeutic agent for respiratory diseases. The present invention pertains to a p... |
|
Invention
|
P2x4 receptor antagonist. 7 represent hydrogen atom and the like, X represents C, CH or N, Y repr... |
|
Invention
|
Composition for increasing muscle mass.
Provided is a composition for increasing muscle mass in ... |
|
Invention
|
Composition for increasing muscle mass. Provided is a composition for increasing muscle mass in a... |
|
Invention
|
Citrate-containing composition, production method and dry method therefor, and tablet containing ... |
|
Invention
|
Use of azepane derivative for treatment, amelioration or prevention of κ-opioid receptor-related ... |
|
Invention
|
Pharmaceutical composition for treatment or prevention of stress-related disorders.
The present ... |
|
Invention
|
Pharmaceutical composition for treatment or prevention of stress-related disorders. The present i... |
2021
|
Invention
|
Intracellular atp enhancer.
Provided is a pharmaceutical composition for enhancing intracellular... |
|
Invention
|
Intracellular atp enhancer. The present invention provides a pharmaceutical composition that is f... |
|
Invention
|
Method for preparing morphinan derivative having diaryl ether skeleton using novel copper catalys... |
|
Invention
|
Pharmaceutical composition for preventing, suppressing, or treating symptom associated with aller... |
|
Invention
|
Sleep quality improver.
Provided is a useful pharmaceutical composition that exhibits effects of... |
|
Invention
|
Renal function protective agent.
To provide a medicine useful for protecting renal function or r... |
2020
|
Invention
|
Pyrazolomorphinan derivative.
The present invention provides a compound having a selective opioi... |
|
Invention
|
Azepane derivative.
Provided are: an azepan derivative represented by general formula (I) and a ... |
|
Invention
|
Reagent cartridge.
Provided is a reagent cartridge that can reduce the risk of infection caused ... |
|
Invention
|
Method for producing phenol derivative.
Provided is a method for producing a phenol derivative r... |
|
Invention
|
Method for producing morphinan derivative. Provided is, for example, a method for producing a mor... |
|
Invention
|
Therapeutic for gout or hyperuricemia.
The present invention provides a pharmaceutical compositi... |
|
Invention
|
Enteric-coated preparation comprising xanthine oxidase inhibitor.
The present invention provides... |
|
Invention
|
Novel pharmaceutical composition.
The present invention relates to a pharmaceutical composition ... |
|
Invention
|
Medicament for preventing or treating irritable bowel syndrome or inflammatory bowel disease.
T... |
|
Invention
|
Use of t-type calcium channel blocker for treating pruritus.
A medicament for treating or preven... |
|
Invention
|
Analysis equipment for medical use |
|
Invention
|
Reagent cartridge |
2019
|
Invention
|
T-type calcium channel blocker.
To provide a novel T-type calcium channel blocker.
To provide ... |
|
G/S
|
Pharmaceutical preparations; Preparations for destroying vermin; Fungicides; Herbicides; Absorben... |
|
G/S
|
Pharmaceuticals, medical and veterinary preparations;
pharmaceutical and veterinary preparations... |
|
G/S
|
Diagnostic reagents, preparations and substances for medical purposes; diagnostic reagents, for m... |
2016
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical or veterinary purpo... |
2015
|
G/S
|
Pharmaceutical products; medicinal products; analgesics; pharmaceutical preparations and substanc... |
|
G/S
|
Pharmaceuticals; diagnostic agent for medical purposes; drug
delivery agents in the form of edib... |
|
G/S
|
Pharmaceuticals; Diagnostic preparations for medical use; Diagnostic preparations for veterinary ... |
|
G/S
|
Therapeutic agent for dysuria; therapeutic agent for breast cancer; anti-platelet aggregation age... |
2009
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; oiled
paper for medical purposes; pharmace... |